Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:sodium_valproate
|
| gptkbp:approvedBy |
1970s
|
| gptkbp:ATCCode |
N03AG01
|
| gptkbp:brand |
gptkb:sodium_valproate
|
| gptkbp:contraindication |
pregnancy
|
| gptkbp:drugClass |
anticonvulsant
mood stabilizer |
| gptkbp:eliminationHalfLife |
9-16 hours
|
| gptkbp:form |
gptkb:tablet
gptkb:water injection |
| https://www.w3.org/2000/01/rdf-schema#label |
Epilim
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
D (high risk)
|
| gptkbp:riskFactor |
pancreatitis
liver toxicity teratogenicity |
| gptkbp:routeOfAdministration |
oral
intravenous |
| gptkbp:sideEffect |
nausea
tremor hair loss weight gain drowsiness |
| gptkbp:usedFor |
bipolar disorder
epilepsy migraine prevention |
| gptkbp:bfsParent |
gptkb:valproic_acid
|
| gptkbp:bfsLayer |
6
|